COLUMVI: Audience

COLUMVI (glofitamab-gxbm) is a prescription medication specifically formulated to treat adults suffering from relapsed or refractory DLBCL after multiple prior therapies. It utilizes a bispecific antibody mechanism to target cancer cells effectively.